肝糖原在2型糖尿病夜间糖异生中的作用
研究比较了糖原负荷(60%碳水化合物)与非糖原负荷(40%碳水化合物)等热量餐对2型糖尿病及无糖尿病者夜间糖异生贡献的影响。结果显示,糖原负荷使两组肝糖原含量和夜间内源性葡萄糖生成均升高(P < .05),2型糖尿病者糖原负荷后糖异生占内源性葡萄糖生成的比例降低,与无糖尿病者的模式一致。
要点
- 糖原负荷较非糖原负荷升高两组肝糖原含量和夜间内源性葡萄糖生成(P < .05)。
- 无糖尿病者夜间糖异生占内源性葡萄糖生成约50%,两种餐后整夜维持该水平。
- 2型糖尿病者糖原负荷后夜间糖异生占内源性葡萄糖生成比例降低,与无糖尿病者模式一致。
核心结论
- 在2型糖尿病中,糖原负荷较非糖原负荷降低夜间糖异生占内源性葡萄糖生成的比例,使其模式与无糖尿病者一致。
- 作者认为,用适当药物选择性靶向夜间糖异生可能减轻2型糖尿病患者的夜间和清晨空腹高血糖及肝脏胰岛素抵抗。
研究设计与样本
- 共纳入14例2型糖尿病受试者和15例匹配的无糖尿病受试者,在过夜状态下随机顺序接受糖原负荷(60%碳水化合物)与非糖原负荷(40%碳水化合物)等热量餐3天。
- 采用[6,6-2H2]葡萄糖输注测定内源性葡萄糖生成,氘标记水测定糖异生,并在餐后和空腹状态进行13C磁共振波谱扫描测定肝糖原含量。
主要发现
- 糖原负荷较非糖原负荷在两组中均升高肝糖原含量和夜间内源性葡萄糖生成(P < .05)。
- 无糖尿病者两种餐后整夜糖异生占内源性葡萄糖生成平均约50%。
- 2型糖尿病者糖原负荷较非糖原负荷降低夜间糖异生占内源性葡萄糖生成的比例,与无糖尿病者糖原负荷后夜间糖异生率降低的模式一致。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Higher gluconeogenesis (GNG) contributes to higher nocturnal endogenous glucose production (EGP) in type 2 diabetes (T2D). Studies using 13C magnetic resonance spectroscopy (MRS) have confirmed lower hepatic glycogen content in subjects with T2D than in subjects with no diabetes (ND). OBJECTIVE: We determined the role of glycogen loading (GL) vs nonglycogen loading (NGL) on the contribution of GNG to nocturnal EGP in T2D. METHODS: In total, 14 subjects with T2D and 15 matched subjects with ND were studied on 2 occasions, with GL (60% carbohydrate) vs NGL (40% carbohydrate) isocaloric meals for 3 days, in random order in the overnight state. [6,6-2H2] glucose was infused to measure EGP, deuterium labelled water was used to measure GNG, and 13C MRS scans were performed in fed and fasted states to measure hepatic glycogen content. RESULTS: Hepatic glycogen content and nocturnal EGP were higher (P < .05) in GL vs NGL in both cohorts. The % GNG to EGP averaged ∼50% in subjects with ND throughout the night after both meals. In contrast, % GNG to nocturnal EGP in T2D was lower with GL vs NGL and matched the pattern observed in subjects with ND with GL lowering overnight rates of GNG in subjects with T2D. CONCLUSION: Selective targeting of GNG at night with appropriate medications could reduce nocturnal and early morning fasting hyperglycemia and hepatic insulin resistance in people with T2D.
引用
- Unni US, Bril F, Mugler JP, et al. Role of Hepatic Glycogen on Nocturnal Gluconeogenesis in Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2025. PMID: 39903644. doi:10.1210/clinem/dgaf044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。